Companies · Other Health Care

Intrapace Inc

San Jose · Other Health Care

Diligence memoA one-page analyst read on Intrapace Inc — recommendation, valuation, rhythm, risks.
$179.1M
Total raised · real
6
Rounds
5.3×
Latest step-up
Top 3%
Sector rank · raised
Series D+
Latest stage · inferred · Mon Aug 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time)

Intrapace Inc looks under-valued against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Under-valued
  • Modeled value is 0.03× the median modeled value of Series D+ Other Health Care companies in 2013–2015 (16 peers) — value vs value, same stage and era.
Dormant
  • Last raise 12.9 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

Intrapace Inc is one of 5377 Other Health Care companies tracked from San Jose. By capital raised it ranks among the largest (ahead of 98% of sector peers), and in the upper tier by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$1.3B$2.5B$3.8B$5.0BSeries D+ · 2010-04-06 Raised $117M (real) Modeled valuation $2.7B (est)$117M$2.7BSeries D+2010Series C · 2010-04-06 Raised $50M (real) Modeled valuation $1.1B (est)$50M$1.1BSeries C2010Series D+ · 2012-04-03 Raised $2.2M (real) Modeled valuation $52M (est)$2.2M$52MSeries D+2012Series D+ · 2012-08-21 Raised $6.2M (real) Modeled valuation $143M (est)$6.2M$143MSeries D+2012Series D+ · 2013-03-18 Raised $624K (real) Modeled valuation $14M (est)$624K$14MSeries D+2013Series D+ · 2013-08-12 Raised $3.3M (real) Modeled valuation $77M (est)$3.3M$77MSeries D+2013+$50M+$2.2M+$6.2M+$624K+$3.3MCumulative $179M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Series D+$116.9M · 2010
Bridge · Series D+-stage$49.8M · 2010smaller follow-on
Series D+ extension$2.2M · 2012
Series D+ extension$6.2M · 2012
Series D+ extension$624K · 2013
Series D+ extension$3.3M · 2013

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Seed, Series A, Series B — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 33%.

Modeled valuation trajectory
$76.8M
Base estimate est.
$17.8M
Conservative case
$168.2M
Upside case
$27.8M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series D+a $100M–$400M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Series D+ · modeled $2.7B · 2010-04-062010Series C · modeled $1.1B · 2010-04-06Series D+ · modeled $51.8M · 2012-04-03Series D+ · modeled $142.7M · 2012-08-21Series D+ · modeled $14.4M · 2013-03-18Series D+ · modeled $76.8M · 2013-08-122013
Model inputs · modeled:benchmark-stage-stepup-v1
12%
Dilution assumption
Implied ownership sold in the financing.
80%
Survival probability
64% low · 88% high
1.23×/yr
Annual markup
1.38×/yr upside case
6.0 yr
Elapsed time used
12.9 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
8 mo
Avg between rounds
$53.4M/yr
Capital velocity
16.2 yr
On record since
2010
First round
6
Rounds on file
How it compares to the market

Benchmarked against 5377 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 74× above median
This company$179.1M
Sector median$2.4M
Latest round — vs other Series D+ rounds in sector (real $, this stage) 0.0× of median
This company$3.3M
Sector median$123.0M
Modeled value — vs sector median (estimate, all stages) 3.5× above median
This company$76.8M
Sector median$22.1M

Raised more than 98% of sector peers (real $). Modeled value above 74% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series D+) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #13 of 16.

This companyCohort peer
$10.0M$100.0M$1.0B$10.0B$100.0B$10.0M$100.0M$1.0BCapital raised (log)Onex TSG Holdings Corp. · Series D+ Raised $336.0M · modeled $7.7B (est)BVO Holdings, LLC · Series D+ Raised $335.8M · modeled $7.7B (est)Mdp Hc Holdings, Llc · Series D+ Raised $310.1M · modeled $7.1B (est)Amsurg Corp · Series D+ Raised $270.9M · modeled $6.2B (est)Greatbatch, Inc. · Series D+ Raised $247.2M · modeled $5.7B (est)Hc Group Holdings Iii, Inc. · Series D+ Raised $144.3M · modeled $3.3B (est)Diplomat Pharmacy, Inc. · Series D+ Raised $140.0M · modeled $3.2B (est)Proteus Biomedical Inc · Series D+ Raised $162.4M · modeled $2.7B (est)Mmi Holdings Inc · Series D+ Raised $109.0M · modeled $2.5B (est)Evolent Health LLC · Series D+ Raised $221.3M · modeled $2.3B (est)BioScrip, Inc. · Series D+ Raised $172.5M · modeled $1.4B (est)Envision Rx Options Holdings, Inc. · Series D+ Raised $144.5M · modeled $80.0M (est)Intrapace Inc (this company) Raised $179.1M · modeled $76.8M (est)Intrapace Inc
CompanyStageRaised · realValue · estvs peer med.
Onex TSG Holdings Corp.Series D+$336.0M$7.7B2.94×
BVO Holdings, LLCSeries D+$335.8M$7.7B2.94×
Mdp Hc Holdings, LlcSeries D+$310.1M$7.1B2.71×
Amsurg CorpSeries D+$270.9M$6.2B2.37×
Greatbatch, Inc.Series D+$247.2M$5.7B2.16×
Hc Group Holdings Iii, Inc.Series D+$144.3M$3.3B1.26×
Diplomat Pharmacy, Inc.Series D+$140.0M$3.2B1.23×
Proteus Biomedical IncSeries D+$162.4M$2.7B1.05×
Mmi Holdings IncSeries D+$109.0M$2.5B0.95×
Evolent Health LLCSeries D+$221.3M$2.3B0.89×
BioScrip, Inc.Series D+$172.5M$1.4B0.55×
Envision Rx Options Holdings, Inc.Series D+$144.5M$80.0M0.03×
Intrapace Inc this companySeries D+$179.1M$76.8M0.03×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Series D+$116.9M2010-04-06$974.3M$2.7B90%
Series C$49.8M2010-04-06$331.8M$1.1B90%
Series D+$2.2M2012-04-03$18.7M$51.8M90%
Series D+$6.2M2012-08-21$51.7M$142.7M90%
Series D+$624K2013-03-18$5.2M$14.4M90%
Series D+$3.3M2013-08-12$27.8M$76.8M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Series D+$116.9M2010-04-06
    • First recorded raise — entered as Series D+.
  2. Series C$49.8M2010-04-06
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 2.3× smaller than the prior — bridge or down round.
  3. Series D+$2.2M2012-04-03
    • Raised again after 24 mo — slower than the ~14 mo sector norm.
    • Round 22.1× smaller than the prior — bridge or down round.
  4. Series D+$6.2M2012-08-21
    • Came back fast: 5 mo vs the ~14 mo sector norm.
    • Round 2.8× larger than the prior — scaling up.
  5. Series D+$624K2013-03-18
    • Came back fast: 7 mo vs the ~14 mo sector norm.
    • Round 9.9× smaller than the prior — bridge or down round.
  6. Series D+$3.3M2013-08-12
    • Came back fast: 5 mo vs the ~14 mo sector norm.
    • Round 5.3× larger than the prior — scaling up.
Intelligence
2014 ~Q2
Modeled next raise · ~8mo cadence
$10.0M
Modeled next size est.range $6.5M$16.0M
5.3×
Last step-up
$53.4M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Eric Bell6 other2010-04
J. Daniel Cole6 other2010-04
Martin Dieck6 other2012-08
TING PAU OEI6 other2010-04
Mir Imran5 other2010-04
Chris Rowland1 other2013-03
Eric R. Bell1 other2012-04
Gary Castro1 other2010-04
Wayne Roe1 other2012-08
Asad Jamal2010-04
Bill McCrone2013-03
Charles Brynelsen2010-04
Charles R. Brynelsen2012-04
Gary Pau Castro2010-04
Gary R. Castro2012-04
Jonathan Daniel Leitersdorf2012-04
Martin Daniel Dieck2012-04
Martin Pau Dieck2010-04
Mir Daniel Imran2012-04
Wayne Daniel Roe2012-04
Wayne Pau Roe2010-04
Registry & provenance

Intrapace Inc is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1162295
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Direct Flow Medical, Inc.Other Health CareSeries C$170.5M$619.6Mnetwork1 shared operator · same sector
Conventus Orthopaedics IncOther Health CareSeries C$144.2M$921.2Mnetwork1 shared operator · same sector
Rallybio Holdings, LLCOther Health CareSeries D+$157.8M$69.6Msame sector · same stage
OPE GEDC Holdings LLCOther Health CareSeries D+$215.0M$82.2Msame sector · same stage
Envision Rx Options Holdings, Inc.Other Health CareSeries D+$144.5M$80.0Msame sector · same stage
Spinal Modulation IncOther Health CareSeries C$76.3M$1.0Bnetwork1 shared operator · same sector
CurvaFix, Inc.Other Health CareSeries C$50.7M$478.1Mnetwork1 shared operator · same sector
Iscience Interventional CorpOther Health CareSeries B$40.3M$61.1Mnetwork1 shared operator · same sector
Frequently asked
How much funding has Intrapace Inc raised?
Intrapace Inc has raised approximately $179.1M in disclosed capital across 6 recorded financing rounds, aggregated from public filings.
What is Intrapace Inc's estimated valuation?
Provath's modeled valuation for Intrapace Inc is approximately $76.8M (modeled range $17.8M–$168.2M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Intrapace Inc at?
Intrapace Inc's latest modeled financing stage is Series D+. Its most recent recorded round closed around Mon Aug 12.
What does Intrapace Inc do and where is it based?
Intrapace Inc operates in the Other Health Care sector, based in San Jose.
Explore related

See where Intrapace Inc sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Intrapace Inc, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.